Difference between revisions of "Part:BBa K4414036"
Line 13: | Line 13: | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem. | + | <img src="https://static.igem.wiki/teams/4414/wiki/36-1.png" class="figure-img img-fluid rounded" height="250px"> |
</figure> | </figure> | ||
Line 27: | Line 27: | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
− | |||
<partinfo>BBa_K4414036 parameters</partinfo> | <partinfo>BBa_K4414036 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
Line 36: | Line 35: | ||
===Method=== | ===Method=== | ||
<html> | <html> | ||
+ | HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414036 and TCE-SEAP(BBa_K4414041). Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 24 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol. [2] | ||
+ | |||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem. | + | <img src="https://static.igem.wiki/teams/4414/wiki/36-2.png |
" class="figure-img img-fluid rounded" height="350px"> | " class="figure-img img-fluid rounded" height="350px"> | ||
Line 44: | Line 45: | ||
</html> | </html> | ||
− | |||
− | |||
===Result=== | ===Result=== | ||
<html> | <html> | ||
− | + | Results showed significantly increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (4.18 folds)(Figure 2). | |
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https:// | + | <img src="https://static.igem.wiki/teams/4414/wiki/36-3.png |
" class="figure-img img-fluid rounded" height="350px"> | " class="figure-img img-fluid rounded" height="350px"> | ||
Line 57: | Line 56: | ||
</html> | </html> | ||
− | |||
− | |||
− | |||
Figure2. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414036. | Figure2. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414036. |
Revision as of 06:06, 9 October 2022
tetR-5xGS linker-LBD
This composite part consists of an N-terminal tetR(BBa_K4414009) domain and a C-terminal NR3C1 LBD(BBa_K4414000) domain fused with a 5xGS(BBa_K4414064) linker. It is designed to sense glucocorticoids and activates the transcription of the reporter gene.
Usage and Biology
As a glucocorticoid sensor, this part is designed to enter the nucleus upon glucocorticoid stimulation and bind to the TCE promoter to activate downstream transcription. This part consists of a tetR DNA binding domain, which binds to the TCE promoter (BBa_K4016011) consisting of seven direct 19-bp tet operator sequence (tetO) repeats. The NR3C1 LBD domain on the C terminal is the ligand�binding domain of the glucocorticoid receptor(GR). This LBD domain can translocate the fusion protein into the nucleus upon glucocorticoid stimulation. It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression.[1]
Figure1. Schematic figure of BBa_K4414036 and BBa_K4414041
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Method
HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414036 and TCE-SEAP(BBa_K4414041). Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 24 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol. [2]
Result
Results showed significantly increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (4.18 folds)(Figure 2).
Figure2. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414036.
Reference
[1]Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174. doi: 10.1038/nrm.2016.152. Epub 2017 Jan 5. PMID: 28053348; PMCID: PMC6257982. [2]Shao J, Qiu X, Xie M. Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol. 2021;2312:35-57. doi: 10.1007/978-1-0716-1441-9_3. PMID: 34228283.